查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1780820

螢光導航手術系統的全球市場

Fluorescence Guided Surgery Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 370 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年，全球螢光導航手術系統市場規模將達到 4.549 億美元

全球螢光導航手術系統市場規模預計在2024年為2.086億美元，到2030年將達到4.549億美元，在2024-2030年的分析期內，複合年成長率為13.9%。 SPY系統是本報告分析的細分市場之一，預計其複合年成長率為13.0%，到分析期結束時將達到2.097億美元。 PDE系統細分市場在分析期間內的複合年成長率預計為13.3%。

美國市場規模估計為 5,680 萬美元，中國市場預計複合年成長率為 18.4%

預計2024年，美國螢光導航手術系統市場規模將達5,680萬美元。作為世界第二大經濟體的中國，預計到2030年市場規模將達到9,630萬美元，在2024-2030年的分析期間內，複合年成長率為18.4%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為10.3%和12.3%。在歐洲，預計德國市場的複合年成長率為11.0%。

全球螢光導航手術系統市場－主要趨勢與促進因素摘要

為什麼螢光導航手術正在改變腫瘤學和神經外科的格局

螢光導引導航手術(FGS) 透過使用螢光染料即時可視化腫瘤、淋巴結和關鍵組織，徹底改變了手術的精準度。該技術在腫瘤科、神經外科和微創手術中尤其重要，因為準確的腫瘤邊緣檢測對於完全切除至關重要。個人化癌症治療的日益普及以及固體癌發生率的上升，推動了對 FGS 系統的需求。此外，近紅外線(NIR) 影像和標靶螢光顯影劑的進步正在提高手術精準度，降低復發率，並改善患者存活率。隨著精準醫療的日益普及，螢光引導手術正成為複雜外科手術的標準。

哪些技術進步正在改善螢光導航手術系統？

分子影像、人工智慧驅動的螢光成像和生物相容性顯影劑的突破正在增強FGS系統的有效性。選擇性結合癌組織的靶向螢光探針的開發正在提高腫瘤的可見性並減少對健康結構的損害。人工智慧驅動的影像軟體能夠即時進行組織分化，從而更有效地指導外科醫生進行手術。此外，將螢光與其他顯像模式（例如MRI和PET掃描）相結合的混合成像系統正在提供多層次的洞察力，以便更好地做出手術決策。機器人輔助螢光引導手術的整合進一步提高了複雜手術的精確度並降低了其侵入性。

監管和市場趨勢如何影響螢光導航手術？

美國食品藥物管理局 (FDA) 和歐洲藥品管理局 (EMA) 等監管機構監督螢光顯影劑和影像系統的核准，確保其安全性和有效性。術中影像和精準腫瘤學日益受到重視，推動了螢光引導成像 (FGS) 在癌症治療方案中的應用。此外，微創手術的需求也促使醫院投資先進的螢光導引腹腔鏡和機器人手術系統。人工智慧輔助手術計畫工具的擴展也影響著市場成長，使其能夠更好地進行術前腫瘤和血管結構的繪製。隨著手術技術的進步，螢光導引手術正成為改善病患預後的重要工具。

什麼將推動螢光導航手術系統市場的未來成長？

人工智慧影像分析、新一代螢光顯影劑以及機器人輔助手術平台的日益普及，正在塑造FGS的未來。針對特定癌症的分子影像染料的開發將進一步提高腫瘤定位和手術精準度。人工智慧決策支援工具將增強即時術中引導，減少手術失誤並提高切除完整性。此外，遠距手術和遠距機器人手術的不斷擴展應用，將使FGS更容易在醫療資源匱乏的地區普及。隨著精準手術需求的不斷成長，螢光導航手術將繼續重新定義現代腫瘤外科和神經外科。

部分

類型（SPY 系統、PDE 系統、VS3 銥系統、其他）、手術（開放性手術、腹腔鏡/內視鏡手術）、應用（癌症手術、心血管手術、其他）

受訪公司範例

  • Accuray Incorporated
  • Arthrex, Inc.
  • Bracco Imaging SpA
  • Curadel LLC
  • Elekta AB
  • Fluoptics
  • Getinge AB
  • Hamamatsu Photonics KK
  • Intuitive Surgical, Inc.
  • Karl Kaps GmbH & Co. KG
  • Karl Storz SE & Co. KG
  • Leica Microsystems（Danaher Corporation）
  • LI-COR Biosciences
  • Lumicell Inc.
  • Medtronic plc
  • Mizuho Medical Co., Ltd.
  • MolecuLight Inc.
  • NICO Corporation
  • Novadaq Technologies Inc.（Stryker）
  • Olympus Corporation

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global 特定產業產業SLM 的典型規範，而是建立了一個從世界各地專家收集的內容庫，包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP31004

Global Fluorescence Guided Surgery Systems Market to Reach US$454.9 Million by 2030

The global market for Fluorescence Guided Surgery Systems estimated at US$208.6 Million in the year 2024, is expected to reach US$454.9 Million by 2030, growing at a CAGR of 13.9% over the analysis period 2024-2030. SPY Systems, one of the segments analyzed in the report, is expected to record a 13.0% CAGR and reach US$209.7 Million by the end of the analysis period. Growth in the PDE Systems segment is estimated at 13.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$56.8 Million While China is Forecast to Grow at 18.4% CAGR

The Fluorescence Guided Surgery Systems market in the U.S. is estimated at US$56.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$96.3 Million by the year 2030 trailing a CAGR of 18.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.3% and 12.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.0% CAGR.

Global Fluorescence Guided Surgery Systems Market - Key Trends & Drivers Summarized

Why Is Fluorescence Guided Surgery Becoming a Game-Changer in Oncology and Neurosurgery?

Fluorescence guided surgery (FGS) is revolutionizing surgical precision by enabling real-time visualization of tumors, lymph nodes, and critical tissues using fluorescent dyes. This technique is particularly valuable in oncology, neurosurgery, and minimally invasive procedures, where precise tumor margin detection is essential for complete resection. The growing adoption of personalized cancer treatment and the increasing prevalence of solid tumors are driving demand for FGS systems. Additionally, advancements in near-infrared (NIR) imaging and targeted fluorescence contrast agents are enhancing surgical accuracy, reducing recurrence rates, and improving patient survival. As precision medicine gains traction, fluorescence guided surgery is becoming a standard in complex surgical interventions.

What Technological Advancements Are Improving Fluorescence Guided Surgery Systems?

Breakthroughs in molecular imaging, AI-powered fluorescence mapping, and biocompatible contrast agents are enhancing the efficacy of FGS systems. The development of targeted fluorescent probes that bind selectively to cancerous tissues is improving tumor visibility and reducing damage to healthy structures. AI-driven imaging software is enabling real-time tissue differentiation, guiding surgeons more effectively during procedures. Additionally, hybrid imaging systems combining fluorescence with other imaging modalities, such as MRI and PET scans, are providing multi-layered insights for better surgical decision-making. The integration of robotic-assisted fluorescence guided surgery is further enhancing precision and reducing invasiveness in complex operations.

How Are Regulations and Market Trends Influencing Fluorescence Guided Surgery?

Regulatory agencies such as the FDA and EMA oversee the approval of fluorescence contrast agents and imaging systems, ensuring their safety and effectiveness. The increasing emphasis on intraoperative imaging and precision oncology is driving the adoption of FGS in cancer treatment protocols. Additionally, the demand for minimally invasive procedures is encouraging hospitals to invest in advanced fluorescence-guided laparoscopic and robotic surgery systems. The expansion of AI-assisted surgical planning tools is also influencing market growth, enabling better preoperative mapping of tumors and vascular structures. As surgical technology evolves, fluorescence guided surgery is becoming an indispensable tool for improving patient outcomes.

What’s Driving the Future Growth of the Fluorescence Guided Surgery Systems Market?

The future of FGS is being shaped by AI-enhanced imaging analytics, next-generation fluorescent contrast agents, and the increasing adoption of robotic-assisted surgical platforms. The development of targeted molecular imaging dyes for specific cancers will further improve tumor localization and surgical precision. AI-powered decision support tools will enhance real-time intraoperative guidance, reducing surgical errors and improving resection completeness. Additionally, the expansion of tele-surgical and remote robotic surgery applications will make FGS more accessible in underserved regions. As demand for precision surgery grows, fluorescence guided surgery will continue to redefine modern surgical oncology and neurosurgery.

SCOPE OF STUDY:

The report analyzes the Fluorescence Guided Surgery Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (SPY Systems, PDE Systems, VS3 Iridium Systems, Other Types); Surgery (Open Surgery, Laparoscopy / Endoscopy Surgery); Application (Cancer Surgery Application, Cardiovascular Surgery Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 37 Featured) -

  • Accuray Incorporated
  • Arthrex, Inc.
  • Bracco Imaging S.p.A.
  • Curadel LLC
  • Elekta AB
  • Fluoptics
  • Getinge AB
  • Hamamatsu Photonics K.K.
  • Intuitive Surgical, Inc.
  • Karl Kaps GmbH & Co. KG
  • Karl Storz SE & Co. KG
  • Leica Microsystems (Danaher Corporation)
  • LI-COR Biosciences
  • Lumicell Inc.
  • Medtronic plc
  • Mizuho Medical Co., Ltd.
  • MolecuLight Inc.
  • NICO Corporation
  • Novadaq Technologies Inc. (Stryker)
  • Olympus Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Fluorescence Guided Surgery Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Preference for Precision-Guided Oncologic Surgeries Propels Market Growth
    • Advancements in Near-Infrared and Multispectral Imaging Improve Visualization Accuracy
    • Increasing FDA and CE Approvals for Targeted Imaging Agents Expand Clinical Use
    • Growing Application in Neurosurgery, Urology, and Reconstructive Surgery Broadens Scope
    • Integration With Robotic Surgery Platforms Enhances Surgical Workflow Synergies
    • Development of Target-Specific Fluorescent Dyes Improves Tumor Margin Identification
    • Growth in Minimally Invasive Surgery Drives Demand for Real-Time Visualization Tools
    • AI-Based Image Enhancement Technologies Enable Faster, More Accurate Interpretation
    • Hospital Investments in Hybrid Operating Rooms Support System Installations
    • Surgeon Training and Awareness Campaigns Boost Institutional Adoption Rates
    • Demand for Organ-Sparing Surgical Techniques Encourages Use in High-Precision Interventions
    • Strategic Collaborations Between Imaging System Manufacturers and Pharma Firms Accelerate Innovation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Fluorescence Guided Surgery Systems Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Fluorescence Guided Surgery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Fluorescence Guided Surgery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for SPY Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for SPY Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for SPY Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for PDE Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for PDE Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for PDE Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for VS3 Iridium Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for VS3 Iridium Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for VS3 Iridium Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Open Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Open Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Open Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Laparoscopy / Endoscopy Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Laparoscopy / Endoscopy Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Laparoscopy / Endoscopy Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Cancer Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Cancer Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Cancer Surgery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cardiovascular Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Cardiovascular Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Cardiovascular Surgery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Fluorescence Guided Surgery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Fluorescence Guided Surgery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Fluorescence Guided Surgery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION